GlassScriptPhysician profile
Nitin Malhotra
NPI 1992970859
$2,399.32
in general payments reported to CMS, 2019-2025
35 companies · $320 in 2025
The $320 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $625 · 2020: $401 · 2021: $261 · 2022: $341 · 2023: $264 · 2024: $188 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $559.86 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Nevro Corp. | $234.97 | 2019-2024 | Senza |
| Abbott Laboratories | $194.81 | 2019-2025 | Proclaim, Octrode |
| Collegium Pharmaceutical, INC. | $122.44 | 2020-2025 | Belbuca |
| Pacira Therapeutics, INC. | $115.04 | 2019-2021 | |
| Si-Bone, INC. | $104.13 | 2019-2022 | |
| Redhill Biopharma INC. | $82.75 | 2020 | |
| Pfizer INC. | $78.81 | 2019-2021 | |
| Electronic Waveform Lab, INC. | $72.25 | 2022 | |
| Abbvie INC. | $72.06 | 2022-2023 | |
| Foundation Fusion Solutions, LLC | $64.65 | 2024-2025 | |
| Depuy Synthes Sales INC. | $60.37 | 2019-2025 | Monovisc, Orthovisc |
| Fidia Pharma USA INC. | $59.41 | 2019-2022 | |
| Horizon Therapeutics Plc | $50.91 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $50.04 | 2019-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $47.62 | 2022-2023 | Genvisc 850 Sodium Hyaluronate |
| Medtronic, INC. | $44.90 | 2023 | Intellis Adaptivestim |
| Valinor Pharma, LLC | $39.17 | 2025 | Movantik |
| Hikma Pharmaceuticals USA | $37.52 | 2022 | |
| Medtronic USA, INC. | $29.00 | 2019-2020 | |
| Ge Healthcare | $28.43 | 2019 | |
| Relievant Medsystems, INC. | $25.00 | 2023 | Intracept |
| Globus Medical, INC. | $24.97 | 2025 | Senza |
| Vertos Medical, INC. | $22.51 | 2021 | |
| Orthogenrx INC. | $22.14 | 2019 | |
| Allergan, INC. | $18.28 | 2022 | |
| Scilex Pharmaceuticals INC. | $17.14 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.78 | 2024 | Iovera, Zilretta |
| Painteq LLC | $16.50 | 2021 | |
| Bioventus LLC | $15.12 | 2019 | |
| Azurity Pharmaceuticals, INC. | $15.02 | 2023 | Horizant |
| Neuronetics, INC. | $14.34 | 2022 | |
| Assertio Therapeutics, INC. | $14.20 | 2019 | |
| Siemens Medical Solutions USA, INC. | $14.17 | 2022 | |
| Stimwave Technologies Incorporated | $14.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitin Malhotra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.